Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma
Mi Jeong Heo, Jessica Yun, Sang Geon Kim
Archives of Pharmacal Research (2019) Vol. 42, Iss. 1, pp. 48-62
Closed Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

The Roles and Mechanisms of lncRNAs in Liver Fibrosis
Zhi He, Deying Yang, Xiaolan Fan, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 4, pp. 1482-1482
Open Access | Times Cited: 102
Relevance of HBx for Hepatitis B Virus-Associated Pathogenesis
Anja Schollmeier, Mirco Glitscher, Eberhard Hildt
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4964-4964
Open Access | Times Cited: 33
Functionalized Carbon Nanotubes for Delivery of Ferulic Acid and Diosgenin Anticancer Natural Agents
Khaled AbouAitah, Ahmed M. Abdelaziz, Imane M. Higazy, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 2, pp. 791-811
Open Access | Times Cited: 11
NAFLD-Associated HCC: Progress and Opportunities
Daniel Geh, Quentin M. Anstee, Helen L. Reeves
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 223-239
Open Access | Times Cited: 47
Liver Cancer: Therapeutic Challenges and the Importance of Experimental Models
Marina Galicia‐Moreno, Jorge Antonio Silva-Gómez, Silvia Lucano‐Landeros, et al.
Canadian Journal of Gastroenterology and Hepatology (2021) Vol. 2021, pp. 1-10
Open Access | Times Cited: 43
A key driver to promote HCC: Cellular crosstalk in tumor microenvironment
Pengyue Liu, Kong Lingyu, Ying Liu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 17
The interactive role of microRNA and other non-coding RNA in hepatitis B (HBV) associated fibrogenesis
Kurt Sartorius, Ying Wang, Benn Sartorius, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Closed Access
Exploring the Putative Involvement of MALAT1 in Mediating the Beneficial Effect of Exendin-4 on Oleic Acid-Induced Lipid Accumulation in HepG2 Cells
Olfa Khalifa, Sama Ayoub, Abdelilah Arredouani
Biomedicines (2025) Vol. 13, Iss. 2, pp. 370-370
Open Access
Complicated crosstalk between HMGA and non-coding RNAs modulates hallmarks of cancer
Lijie Zhang, Xiaomin Zhao, Xianhua Gao, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Noncoding RNA-mediated macrophage and cancer cell crosstalk in hepatocellular carcinoma
Zhixia Zhou, Zhan Wang, Jie Gao, et al.
Molecular Therapy — Oncolytics (2022) Vol. 25, pp. 98-120
Open Access | Times Cited: 19
Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma
Saleh A. Alqahtani, Wah‐Kheong Chan, Ming‐Lung Yu
Clinics in Liver Disease (2023) Vol. 27, Iss. 2, pp. 211-223
Closed Access | Times Cited: 12
Bioinformatics analysis of a disease-specific lncRNA–miRNA–mRNA regulatory network in recurrent spontaneous abortion (RSA)
Somayeh Reiisi, Kambiz Ahmadi
Archives of Gynecology and Obstetrics (2024) Vol. 309, Iss. 4, pp. 1609-1620
Closed Access | Times Cited: 4
Circular RNA expression and circPTPRM promotes proliferation and migration in hepatocellular carcinoma
Zhun Luo, Xuelan Mao, Wei Cui
Medical Oncology (2019) Vol. 36, Iss. 10
Closed Access | Times Cited: 34
LncRNAs Act as a Link between Chronic Liver Disease and Hepatocellular Carcinoma
Young-Ah Kim, Kwan‐Kyu Park, Sun-Jae Lee
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 2883-2883
Open Access | Times Cited: 29
Engineered nanoparticles to enhance natural killer cell activity towards onco-immunotherapy: a review
Cao Dai Phung, Tuan Hiep Tran, Jong Oh Kim
Archives of Pharmacal Research (2020) Vol. 43, Iss. 1, pp. 32-45
Closed Access | Times Cited: 26
Exosomal microRNAs as diagnostic and therapeutic biomarkers in non-malignant liver diseases
Seonghwan Hwang, Yoon Mee Yang
Archives of Pharmacal Research (2021) Vol. 44, Iss. 6, pp. 574-587
Open Access | Times Cited: 23
LncRNA SNHG16 promotes epithelial-mesenchymal transition by upregulating ITGA6 through miR-488 inhibition in osteosarcoma
Jie Bu, Ru Guo, Xue-Zheng Xu, et al.
Journal of bone oncology (2021) Vol. 27, pp. 100348-100348
Open Access | Times Cited: 22
The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC
Ioana Rusu, Radu Pîrlog, Paul Chiroi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12370-12370
Open Access | Times Cited: 15
Novel delivery system with a dual–trigger release of savory essential oil by mesoporous silica nanospheres and its possible targets in leukemia cancer cells: in vitro study
Khaled AbouAitah, Heba A. Hassan, Naglaa M. Ammar, et al.
Cancer Nanotechnology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 8
LINC00689 participates in proliferation, chemoresistance and metastasis via miR-31-5p/YAP/β-catenin axis in colorectal cancer
Yongliang Du, Yan Liang, Guang-Qing Shi, et al.
Experimental Cell Research (2020) Vol. 395, Iss. 1, pp. 112176-112176
Closed Access | Times Cited: 21
Progress on traditional Chinese medicine in improving hepatic fibrosis through inhibiting oxidative stress
Zhen Li, Jun-Feng Zhu, Hao Ouyang
World Journal of Hepatology (2023) Vol. 15, Iss. 10, pp. 1091-1108
Open Access | Times Cited: 7
LncRNA NEAT1 in the pathogenesis of liver‐related diseases
Raed Obaid Saleh, Adnan Taan Alkhafaji, Mohammed Sani Jaafaru, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 3
Closed Access | Times Cited: 2
Construction of a cell cycle specific lncRNA-miRNA-mRNA network reveals novel key lncRNAs in colorectal cancer
Marzieh Naderi Boldaji, Shahrzad Shahbazi, Somayeh Reiisi, et al.
Biomarkers (2024), pp. 1-14
Closed Access | Times Cited: 2
Can small nucleolar RNA be a novel molecular target for hepatocellular carcinoma?
Shuwen Han, Yang Xi, Qi Quan, et al.
Gene (2020) Vol. 733, pp. 144384-144384
Closed Access | Times Cited: 18
Role of long non‑coding RNAs and related epigenetic mechanisms in liver fibrosis (Review)
Niladri Ganguly, Subrata Chakrabarti
International Journal of Molecular Medicine (2021) Vol. 47, Iss. 3
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top